[PDF][PDF] A phase 1, 2-part, multicenter, first-in-human, dose-escalation and dose-expansion study of DS-1103a with trastuzumab deruxtecan (T-DXd) in patients with …
INTRODUCTION OBJECTIVES METHODS ENROLLMENT STATUS Page 1 A phase 1, 2-part,
multicenter, first-in-human, dose-escalation and dose-expansion study of DS-1103a with …
multicenter, first-in-human, dose-escalation and dose-expansion study of DS-1103a with …